Keyphrases
Let-7
100%
Tumor Progression
100%
MicroRNA
100%
MiR-200
76%
Cancer Progression
46%
Cancer Cells
30%
Oncofetal
23%
Human Cancer
23%
Epithelial-mesenchymal Transition
23%
Tumor Cells
23%
In Cancer
23%
Profile Type
15%
Gene Expression Profile
15%
Early Cancer
15%
RNA Molecules
15%
Embryogenesis-related Genes
7%
Long RNAs
7%
Early Embryo
7%
ZEB2
7%
Cancer 2
7%
Dedifferentiation
7%
Epithelial Phenotype
7%
Differentiation Process
7%
Tool Detection
7%
Fas Ligand
7%
Embryonic Cells
7%
Invasive Properties
7%
Advanced Ovarian Cancer
7%
Cancer Growth
7%
Small Interfering RNA (siRNA)
7%
MiRNA Target
7%
Advanced Cancer
7%
Cancer Therapy
7%
Drug Resistance
7%
Ovarian Cancer Patients
7%
Diagnostic Tool
7%
HMGA2
7%
Epithelial Cells
7%
Taxanes
7%
Specific Intent
7%
Public Health
7%
Zinc Finger E-box Binding Homeobox 1 (ZEB1)
7%
Chemotherapy
7%
Cancer Diagnostics
7%
Inducer
7%
Cancer Stage
7%
Family Members
7%
Bioinformatics Analysis
7%
Cellular Processes
7%
Messenger RNA (mRNA)
7%
E-cadherin
7%
Regulated Genes
7%
Metastasis
7%
Invasive Cancer
7%
Cancer Treatment
7%
Apoptosis-inducing Activity
7%
Transcription Factor
7%
Pharmacology, Toxicology and Pharmaceutical Science
Tumor Growth
100%
microRNA
100%
microRNA 200
81%
Malignant Neoplasm
72%
Cancer Growth
63%
Neoplasm
27%
Early Cancer
18%
Cellular Processes
9%
Chemotherapy
9%
Advanced Cancer
9%
Ovary Cancer
9%
Uvomorulin
9%
Tumor Invasion
9%
Fas Ligand
9%
Transcription Factors
9%
Drug Resistance
9%
Messenger RNA
9%
Taxane
9%
Biochemistry, Genetics and Molecular Biology
MicroRNA
100%
Mir-200
100%
Tumor Progression
100%
Cancer Cell
44%
Mesenchymal-Epithelial Transition
33%
Gene Expression
22%
RNA
11%
ZEB2
11%
ZEB1
11%
HMGA2
11%
Transcription Factors
11%
Fas Ligand
11%
Cell Dedifferentiation
11%
Drug Resistance
11%
Messenger RNA
11%
Cadherin
11%
Bioinformatics
11%
Small RNAs
11%
Programmed Cell Death
11%